Inventor · disambiguated record
Allison L. Marlow
Also filed as: MARLOW ALLISON L
27 granted patents·9 pending applications·297 citations·filing 1998–2012
97Inventor score
Top patents by PatentIndex Score
36 records- 0196US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 0296US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 0396US7425637B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2005·Granted Sep 16, 2008·27 cites·1 claims
- 0494US7777050B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 17, 2010·13 cites·9 claims
- 0593US7235537B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jun 26, 2007·53 cites·10 claims
- 0692US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 0791US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 0891US7538120B2Method of treating inflammatory diseasesARRAY BIOPHARMA INC·Filed 2005·Granted May 26, 2009·11 cites·9 claims
- 0989US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 1088US7576114B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 18, 2009·5 cites·1 claims
- 1186US8513293B2Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammalWALLACE ELI M·Filed 2012·Granted Aug 20, 2013·5 cites·4 claims
- 1286US8003805B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2010·Granted Aug 23, 2011·5 cites·7 claims
- 1386US7973170B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2010·Granted Jul 5, 2011·5 cites·7 claims
- 1486US7723330B2Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted May 25, 2010·11 cites·58 claims
- 1583US8178693B2N3 alkylated benzimidazole derivatives as MEK inhibitorsWALLACE ELI M·Filed 2010·Granted May 15, 2012·4 cites·14 claims
- 1683US8003662B2Heterobicyclic thiophene compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·9 cites·9 claims
- 1781US8101639B26-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereofMARLOW ALLISON L·Filed 2009·Granted Jan 24, 2012·4 cites·6 claims
- 1881US7576072B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Aug 18, 2009·9 cites·18 claims
- 1980US9133187B2Serine/threonine kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Sep 15, 2015·6 cites·20 claims
- 2080US8193230B2Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereofWALLACE ELI M·Filed 2010·Granted Jun 5, 2012·2 cites·4 claims
- 2180US8193231B2Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereofWALLACE ELI M·Filed 2010·Granted Jun 5, 2012·2 cites·4 claims
- 2280US8101611B2Substituted pyridazines inhibitors of MEKMARLOW ALLISON L·Filed 2011·Granted Jan 24, 2012·4 cites·10 claims
- 2379US7842816B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Nov 30, 2010·3 cites·10 claims
- 2478US8193229B2Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitorsWALLACE ELI M·Filed 2010·Granted Jun 5, 2012·2 cites·14 claims
- 2575US8211920B26-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereofMARLOW ALLISON L·Filed 2008·Granted Jul 3, 2012·1 cites·16 claims
- 2660US2012263679A1Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use ThereofMARLOW ALLISON L·Filed 2012·Application pending·0 cites
- 2760US2013018075A1Heterocyclic inhibitors of mek and methods of use thereofMARLOW ALLISON L·Filed 2012·Application pending·0 cites
- 2858US2003232869A1N3 alkylated benzimidazole derivatives as MEK inhibitorsFiled 2003·Application pending·0 cites
- 2958US2011178136A1Heterocyclic inhibitors of mek and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Application pending·0 cites
- 3056US2011288092A1Heterocyclic Inhibitors of MEK and Methods of Use ThereofMARLOW ALLISON L·Filed 2010·Application pending·0 cites
- 3155US2006106225A1N3 alkylated benzimidazole derivatives as MEK inhibitorsWALLACE ELI M·Filed 2005·Application pending·0 cites
- 3248US8299076B2Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamideMARLOW ALLISON L·Filed 2006·Granted Oct 30, 2012·0 cites·24 claims
- 3348US2003216460A1N3 alkylated benzimidazole derivatives as MEK inhibitorsFiled 2003·Application pending·0 cites
- 3444US2011053931A1Quinoline compounds and methods of useGAUDINO JOHN·Filed 2007·Application pending·0 cites
- 3541US2010256356A1Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 3626US6448400B1Self-assembled ionophoresUNIV MARYLAND·Filed 1998·Granted Sep 10, 2002·0 cites·49 claims
Join the waitlist — get patent alerts
Get an alert when Allison L. Marlow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →